Anika to Participate in Upcoming Investor Conferences

Rhea-AI Summary

Anika Therapeutics, Inc. (NASDAQ: ANIK) to participate in investor conferences at Stephens Annual Investment Conference and Piper Sandler 35th Annual Healthcare Conference. Dr. Cheryl Blanchard and Michael Levitz will present live and host 1x1 investor meetings. Webcasts and presentation archives available on Anika's website.

Positive

• Anika Therapeutics, Inc. is actively engaging with investors and presenting at two major investor conferences, signaling confidence in the company's growth and future prospects.
• Participation in investor conferences provides Anika Therapeutics, Inc. with an opportunity to showcase its leadership and financial management, potentially attracting new investors and strengthening existing relationships.

Negative

• None.

BEDFORD, Mass., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that Dr. Cheryl Blanchard, President and Chief Executive Officer and Michael Levitz, Executive Vice President, Chief Financial Officer and Treasurer, will be participating at the following investor conferences:

• The Stephens Annual Investment Conference at the Grand Hyatt, Nashville, TN, on Wednesday, November 15, 2023. The Company will host a live presentation starting at 8:00 a.m. CT/9:00 a.m. ET. Management will be hosting 1x1 investor meetings the same day.
  
• The Piper Sandler 35^th Annual Healthcare Conference at the Lotte New York Palace on Wednesday, November 29, 2023. The Company will host a live presentation starting at 2:50 p.m. ET. Management will be hosting 1x1 investor meetings the same day.
  

Webcasts of all events will be available in the Investor Relations section of Anika’s website, www.anika.com. An archive of the all the presentations will also be available on the website.

About Anika

Anika Therapeutics, Inc. (NASDAQ: ANIK), is a global joint preservation company that creates and delivers meaningful advancements in early intervention orthopedic care. Leveraging our core expertise in hyaluronic acid and implant solutions, we partner with clinicians to provide minimally invasive products that restore active living for people around the world. Our focus is on high opportunity spaces within orthopedics, including Osteoarthritis Pain Management, Regenerative Solutions, Sports Medicine and Arthrosurface Joint Solutions, and our products are efficiently delivered in key sites of care, including ambulatory surgery centers. Anika’s global operations are headquartered outside of Boston, Massachusetts. For more information about Anika, please visit www.anika.com.

ANIKA, ANIKA THERAPEUTICS and the Anika logo are registered trademarks of Anika Therapeutics, Inc.

For Investor Inquiries:
Anika Therapeutics, Inc.
Mark Namaroff, 781-457-9287
Vice President, Investor Relations, ESG and Corporate Communications
investorrelations@anika.com

FAQ

What conferences will Anika Therapeutics, Inc. be participating in?

Anika Therapeutics, Inc. will be participating in the Stephens Annual Investment Conference and the Piper Sandler 35th Annual Healthcare Conference.

Who will be presenting at the conferences?

Dr. Cheryl Blanchard, President and Chief Executive Officer, and Michael Levitz, Executive Vice President, Chief Financial Officer and Treasurer, will be presenting at the conferences.

Where can I access the webcasts of the events?

Webcasts of all events will be available in the Investor Relations section of Anika’s website, www.anika.com.

Will the presentations be available after the events?

Yes, an archive of all the presentations will be available on Anika's website.